Authors


Peter Sturtevant, GS1 US

Latest:

The march to DSCSA interoperability

Barcode assessment project demonstrates the ground gained in meeting serialization-readiness requirements for supply chain transparency


Mark McGraw

Latest:

Strategic Insight and Forecasting: From Pipeline to Pharmacy

How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.


Vishal Singal and Nalini Somavarapu, Axtria

Latest:

Patient Hubs in an Omnichannel World

How personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes.



Jay Johnson, Labelmaster

Latest:

Dealing with Dangerous Goods

The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic


Charles Pirraglia and Deborah Brown

Latest:

What Pharma Companies Need to Know About Entering the Great White North

Product commercialization in Canada is by no means simple, but the end result presents its advantages


Alf Goebel, Advanco

Latest:

Counterfeit Meds: Fighting the Forgers

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.


DeSpir Logistics

Latest:

Safeguarding Time and Temperature Sensitive Pharma

When identifying a third-party service provider for ground transport of pharmaceutical freight, it is essential that the shipper partner with a company equipped with the expertise and technologies to plan for and monitor necessary shipments as well as respond to issues that may compromise the freight along its journey.


SkyCell 

Latest:

Three criteria for choosing pharma containers 

The top criteria to consider when evaluating and choosing the right airfreight container that can efficiently protect pharma’s cold chain 


Dan Sontupe and John Knutila, The Value Builders

Latest:

The Synergies in Combining Artificial Intelligence and Market Access

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?


Philip Daniels and Rebecca Lorenzo, Axtria

Latest:

Marketing Data Hubs: When Operations and Analytics Collide

How to best plan out and implement a marketing data hub as a key tool to harnessing today’s omnichannel transformation in pharma




Polar Leasing

Latest:

-30C Walk-In Freezer Product Spotlight

From research and development to the clinical trials phase, pre-conditioning gel packs and PCMs prior to transport, Polar Leasing temperature-controlled chamber rentals are the perfect on-site solution for temporary refrigeration anywhere throughout the cold chain. Learn about our -30C Walk-In Freezer and its features now.


Nitin Raizada, Arindam De, Durgagauri Sabnis

Latest:

5 Ways to Tackle Patient Non-Adherence

Five strategies to help pharma companies improve their return on investment from adherence-promoting initiatives and drive positive health outcomes for patients


Sadia Ahmed

Latest:

eCTD 4.0: Implementation Best Practices

With the standard constantly evolving across the pharma sector, the latest version can help bring benefits to the regulatory process.


Adlai Goldberg, EY

Latest:

The Key Force in CGT Commercialization

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum


Karina Castagna

Latest:

Engaging HCPs to Improve Brand Access and Retention with Digital Point of Care and Sales Technology

What does digital innovation actually mean and how is it changing the way that pharma is interacting with HCPs and patients?



Jim Banigan, Conduent

Latest:

Hub Programs from Patient Perspective

Disruption is the order of the day to create a more individual-centric hub experience from the patient’s point of view


PCI Pharma Services

Latest:

Viable Options: Packaging and Partnering for Successful Storage and Transport of Conventional Cold-Chain Vaccines for Covid-19

***Live: Thursday, February 25, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions. *** On demand until Feb. 25, 2022**


Dean Alms, Aravo

Latest:

Prescribing Resilience: Third-Party Risks and Pharma

What stands between pharma and other industries when it comes to remaining vigilant?


Brandon Newman

Latest:

A Closer Look at PBM Spread Pricing

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector.


William Borden

Latest:

The Risk of Doubling Down on Pharma

Examining the divestment risks, as more large companies look to spin off consumer health and other business units to focus on branded pharmaceuticals


Model N

Latest:

Navigating New State Drug Price Transparency Laws

As the State Drug Pricing Transparency Program expands, what does that mean for manufacturers? Jesse Mendelsohn, Vice President, Centers of Excellence for Model N, the leader in cloud revenue management solutions for life science companies, discusses challenges for manufacturers as the State Price Transparency Program expands how they should plan for this change and the solutions they will need.


Elle Kowal

Latest:

Keep Supply Chains Flowing with Streamlined Healthcare Vendor Payments

Vendor relationships are best supported by practices that emphasize efficiency, visibility, and the streamlining of the invoice to pay process


Srini Rajamani, Wipro

Latest:

Transforming Pharma Supply Chains for the Age of Personalized Care

A prediction of how this shift toward patient-centric care may look.


Danial Arkwell, PhD

Latest:

How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease Patients

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.


Dave Ehlert

Latest:

Algorithms and accountability

Drug shortages are inevitable—being caught off guard isn’t. The best ways distributors can use and position data to drive today’s inventory solutions


Fran Gregory, PharmD, MBA

Latest:

Getting the Lay of the Land After a Banner Year for Biosimilars

Biosimilars market experiences massive growth, but regulatory and adoption challenges remain.

© 2024 MJH Life Sciences

All rights reserved.